Karuna Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
290.11
|
|
Average Rating
|
4.65
|
|
# Strong Buys
|
13
|
|
# Buys
|
7
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-2.13
|
-2.38
|
-0.25
|
-11.74%
|
|
2022-06-30
|
-2.09
|
-2.17
|
-0.08
|
-3.83%
|
|
2022-03-31
|
-2.11
|
-1.95
|
0.16
|
7.58%
|
|
2021-12-31
|
-1.73
|
-0.94
|
0.79
|
45.66%
|
|
2021-09-30
|
-1.44
|
-1.72
|
-0.28
|
-19.44%
|
|
2021-06-30
|
-1.34
|
-1.17
|
0.17
|
12.69%
|
|
2021-03-31
|
-1.13
|
-1.10
|
0.03
|
2.65%
|
|
2020-12-31
|
-0.89
|
-0.89
|
0.00
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-6.50
|
|
2021-12-31
|
-4.93
|
|
2020-12-31
|
-2.58
|
|
2019-12-31
|
-2.46
|